(88 days)
Innovasive Devices, Inc., ACL Clip-In is indicated for use in the fixation of ligament and tendon grafts in cruciate ligament reconstruction surgeries.
The ACL Clip-In device is a two component implant used in the fixation of ligament and tendon grafts in cruciate ligament reconstruction surgeries. The two device components are the Base and the Eyelet which are assembled together in the bone during the surgical procedure. The ACL Clip-In device consists of an outer threaded Base which is designed to be endoscopically delivered through a prepared tibio-femoral tunnel and manually inserted into the antero-lateral femur using a hex driver. The proximal end of the Base has a flexible wire assembled to it. The Eyelet has a smooth transverse opening to accept the soft tissue without damaging it. The proximal end of the Eyelet has a circular groove which is of a larger diameter of the flexible wire in the Base. The flexible wire provides for a spring like property as the Eyelet passes through the Base. When the proximal end of the Eyelet engages with the flexible wire, it locks the Eyelet in place. With regard to implant size, the Base comes in 8mm, 10mm and 12mm diameters. The Eyelets are size specific and can be used only with the specified base component. The components will be labeled to indicate the same.
This 510(k) summary (K973323) describes the ACL Clip-In device, its indications for use, technological characteristics, and a comparison to a predicate device to demonstrate substantial equivalence. The summary focuses on performance testing to support this claim, rather than a study with acceptance criteria in the typical sense of a diagnostic or screening device.
Here's an analysis of the provided information:
1. A table of acceptance criteria and the reported device performance
The document does not specify quantitative acceptance criteria. Instead, it states that the subject device demonstrated "at a minimum equivalent or better performance compared to the selected predicate device" in various comparative tests.
| Performance Metric | Acceptance Criteria (Implicit) | Reported Device Performance |
|---|---|---|
| Strength of implant-implant interface | Equivalent or better than predicate device | Demonstrated equivalent or better performance compared to the selected predicate device. |
| Strength of implant-graft-host bone construct (Static) | Equivalent or better than predicate device | Demonstrated equivalent or better performance compared to the selected predicate device. |
| Strength of implant-graft-host bone construct (Dynamic) | Equivalent or better than predicate device | Demonstrated equivalent or better performance compared to the selected predicate device. |
| Host Bone-Implant Interface (Post-test evaluation) | Equivalent or better than predicate device | Demonstrated equivalent or better performance compared to the selected predicate device. |
| Graft-Implant Interface (Post-test evaluation) | Equivalent or better than predicate device | Demonstrated equivalent or better performance compared to the selected predicate device. |
| Graft Incorporation (Post-test evaluation) | Essentially identical to predicate device | Provisions for graft incorporation are essentially identical between subject and predicate devices. |
2. Sample sized used for the test set and the data provenance
The document does not explicitly state the sample size used for the comparative testing. It only mentions "comparative testing with a selected predicate device."
The provenance of the data is not specified in terms of country of origin or whether it was retrospective or prospective. Given the nature of a 510(k) submission for a medical device of this type, the testing would typically be prospective pre-clinical (bench or cadaveric) and conducted by the manufacturer.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
This section is not applicable to this submission. The device is a direct-fixation implant, and the assessment is based on physical and mechanical properties, not interpretation by experts. Ground truth, in this context, refers to objective measurements of strength, interface integrity, and other mechanical parameters.
4. Adjudication method for the test set
This section is not applicable. As there is no human interpretation involved in establishing "ground truth," no adjudication method is required. The assessment is based on mechanical test results.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
A multi-reader multi-case (MRMC) comparative effectiveness study is not applicable to this device. This type of study is used for diagnostic or screening devices involving human interpretation, often assisted by AI. The ACL Clip-In is a surgical implant.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
This section is not applicable as the device is a physical implant, not an algorithm.
7. The type of ground truth used
The "ground truth" for the performance testing was derived from objective mechanical and physical measurements of the implant's properties and its interaction with graft and bone surrogates. This includes:
- Strength measurements (static and dynamic loads)
- Evaluation of interface integrity (implant-implant, implant-graft, host bone-implant)
- Assessment of features related to graft incorporation.
8. The sample size for the training set
This section is not applicable. The ACL Clip-In is a medical device, not an AI/ML algorithm that requires a "training set." Performance is evaluated through direct mechanical testing.
9. How the ground truth for the training set was established
This section is not applicable for the same reason as point 8.
{0}------------------------------------------------
510 (K) SUMMARY
DEC - 1 1997
- Date of Summary Preparation 1 Sept. 2, 1997
Submitter's Name & Address 2 Innovasive Devices, Inc. 734 Forest Street, Marlborough, MA 01752 Telephone: 508-460-8229 508-460-8997 Fax:
- 3 Contact Person MR. Eric Bannon Vice President, QA/RA
4 Manufacturer's Contact Person
Mr. T. Wade Fallin Exec. Vice President Innovasive Devices, Inc. 180 South 600 West Logan, UT 84321 Telephone: 801-753-7675 Fax: 801-753-7698
- 5 Proprietary Device Name ACL Clip-In
- 6 Common Name Endosteal Fixation Device
7 Classification Name
Smooth or Threaded Metallic Bone Fixation Fastener. Single/multiple component bone fixation appliances and accessories
- 8 Classification Reference 21CFR 888.3030
- 9 Device Product Code 87 MBI
- 10 Regulatory Class Class II
{1}------------------------------------------------
11 Materials
The following material is used in the manufacturing of the Base and Eyelets. Ti-6A1-4V ELI per ASTM F-136. Nitinol Wire (Ni-Ti Alloy)
Indications for Use 12
Innovasive Devices, Inc., ACL Clip-In is indicated for use in the fixation of ligament and tendon grafts in cruciate ligament reconstruction surgeries.
Description 13
Intended Use
The Innovasive Devices, Inc., ACL Clip-In is intended to be a fixation device in the repair of tendons and ligaments in Cruciate Reconstructive surgery.
Technological Characteristics
The ACL Clip-In device is a two component implant used in the fixation of ligament and tendon grafts in cruciate ligament reconstruction surgeries. The two device components are the Base and the Eyelet which are assembled together in the bone during the surgical procedure.
The ACL Clip-In device consists of an outer threaded Base which is designed to be endoscopically delivered through a prepared tibio-femoral tunnel and manually inserted into the antero-lateral femur using a hex driver. The proximal end of the Base has a flexible wire assembled to it.
The Eyelet has a smooth transverse opening to accept the soft tissue without damaging it. The proximal end of the Eyelet has a circular groove which is of a larger diameter of the flexible wire in the Base. The flexible wire provides for a spring like property as the Eyelet passes through the Base. When the proximal end of the Eyelet engages with the flexible wire, it locks the Eyelet in place.
With regard to implant size, the Base comes in 8mm, 10mm and 12mm diameters. The Eyelets are size specific and can be used only with the specified base component. The components will be labeled to indicate the same.
Substantially Equivalent Predicate Devices 14
| FRA BBLE | ||||||
|---|---|---|---|---|---|---|
| .1 8 ---100 100 100 | -40 D --------S | יינוC | .1991 - 1991 - 1991 - 1991 - 1991 - 1991 - 1991 - 1991 - 1991 - 1991 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 -THE CA | 00 | ||
| MANUFACTURER'SNAME | DEVICE NAME | 510(k) DOCUMENT NO. | 510(k)CLEARED |
|---|---|---|---|
| Innovasive Devices,Marlborough, MA | 8mm Ligamentfastener | K970316 | Yes |
{2}------------------------------------------------
Substantial Equivalence 15
15.1 Technological Characteristics
15.1.1 Similarities
- (a) The ACL Clip-In device shares very similar technological characteristics with the predicate device. Both devices have:
-
- a bone fixation element, and
-
- a linkage element that connects the graft to the bone fixation element.
-
- (b) The bone fixation element is an externally threaded, internally cannulated Base.
- (c) The linkage element is an Eyelet with a transverse opening for receiving the graft and a proximal pin which locks into the Base.
15.1.2 Technological Differences
The ACL Clip-in uses different materials that the predicate device.
15.2 Rationale for Differences
- (a) The subject device uses a well proven material which provides for greater strength and biocompatability.
- (b) Another potential clinical advantage is afforded by the connection means between the bone fixation element and the linkage element. This connection provides an axial lock, but will allow for rotational movement. Thus, the surgeon can adjust graft position along the axis of the bone tunnel after the linkage element, with graft attached, is connected to the bone fixation element. This is accomplished by engaging the Clip-In removal tool on the distal end of the Eyelet and turning it to reposition the graft in a distal to inferior direction.
- (c) A further potential clinical advantage is the ability to disengage the linkage element from the bone fixation element without damaging the linkage element or the graft by use of a simple removal punch. This may be an advantage in the event that the surgeon may need to reconfigure the linkage-graft construction. This removal tool engages the proximal end of the assembled bone fixation element and linkage element, and provides release with a rotationally directed compression force. Also provided is a implant removal tool, which helps unthread the assembly (base + eyelet) via the tibio-femoral tunnel.
16 Performance Data
No performance standards exist at this time for the regulatory class under which the ACL Clip-in is proposed for classification. However, in support of this submission, Innovasive
{3}------------------------------------------------
Devices, Inc. has conducted the voluntary device testing in order to assess the effects of the new technological characteristics on the modes of failure of the device.
The effects of different materials on the modes of failure of the subject device were assessed in comparative testing with a selected predicate device.
The testing performed was:
- Strength of implant-implant interface .
- Strength of implant-graft-host bone construct .
- a. Static
- b. Dynamic
Post-test evaluation included:
- Host Bone- Implant Interface ●
- Graft Implant Interface ●
- Graft Incorporation
With regard to testing, the subject device demonstrated at a minimum equivalent or better performance compared to the selected predicate device in each of the three tests outlined above. With regard to post test evalutaion, the subject device demonstrate equivalent or better performance compared to the selected predicate device in post dynamic test evaluations of the host bone-implant interface and the graft-implant interface. Provisions for graft incorporation are essentially identical between the subject and predicate devices, as all provide transverse support of the soft tissue loop and all provide the same amount of graft-host bone surface area contact to facilitate graft incorporation.
17 Conclusion
Based on the design concept, use of standard material, feature comparisons to a selected predicate device, the device and predicate device testing, Innovasive Devices, Inc. believes that sufficient evidence exists to conclude that the ACL Clip-In Device is substantially equivalent to existing legally marketed endosteal fixation devices.
{4}------------------------------------------------
Image /page/4/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized image of an eagle or bird with three curved lines forming its body and wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the bird. The text is in all capital letters and is evenly spaced around the circle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
DEC - 1 1997
Mr. Eric Bannon ·Vice President, Quality Assurance/Regulatory Affairs Innovasive Devices, Inc. 734 Forest Street 01752 Marlborough, Massachusetts
K973323 Re: ACL Clip-In Trade Name: Regulatory Class: II Product Code: MBI and HWC Dated: September 2, 1997 Received: September 4, 1997
Dear Mr. Bannon:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions The general controls provisions of the Act of the Act. include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical General regulation (21 CFR Part 820) and that, Devices: through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory In addition, FDA may publish further announcements action. concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
{5}------------------------------------------------
Page 2 - Mr. Eric Bannon
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to
premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Celia M. Witten, Ph.D., M.
Cella M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{6}------------------------------------------------
INDICATIONS FOR USE 3.
3.1 Statement of Indications for Use
Innovasive Devices, Inc. (IDI) - ACL Clip-In is indicated for use in the fixation of ligament and tendon grafts in cruciate ligament reconstruction surgeries.
Prescription Use
(Per 21 CFR 801.109)
Acolla
Divis 510k) I
§ 888.3040 Smooth or threaded metallic bone fixation fastener.
(a)
Identification. A smooth or threaded metallic bone fixation fastener is a device intended to be implanted that consists of a stiff wire segment or rod made of alloys, such as cobalt-chromium-molybdenum and stainless steel, and that may be smooth on the outside, fully or partially threaded, straight or U-shaped; and may be either blunt pointed, sharp pointed, or have a formed, slotted head on the end. It may be used for fixation of bone fractures, for bone reconstructions, as a guide pin for insertion of other implants, or it may be implanted through the skin so that a pulling force (traction) may be applied to the skeletal system.(b)
Classification. Class II.